-
Medtronic Receives US Approval for InPen App with Missed Meal Dose Detection
•
US-Irish firm Medtronic (NYSE: MDT) has announced US market approval for its new InPen app, which features missed meal dose detection. This innovation marks a significant step in the launch of Medtronic’s Smart MDI system, integrated with the Simplera continuous glucose monitor (CGM). InPen App: A Pioneer in Real-Time Insulin…
-
Yixintang Partners with Huawei Cloud to Drive Digital Transformation in Pharma Retail
•
Yixintang Pharmaceutical Group Co., Ltd. (SHE: 002727), a prominent pharmaceutical retail chain in China, has entered into a strategic partnership with telecom giant Huawei Cloud. The collaboration aims to enhance information infrastructure, develop data-enabled platforms, and innovate within the burgeoning health industry, all while driving the digital and intelligent transformation…
-
Siemens Healthineers AG and Shandong First Medical University’s College of Radiology Collaborate on Medical Imaging Metaverse
•
Siemens Healthineers AG (ETR: SHL), a leading life sciences company based in Germany, has entered into a strategic partnership with the College of Radiology at Shandong First Medical University. The collaboration aims to encompass several key initiatives: The duo will jointly construct China’s inaugural “Medical Imaging Metaverse Immersive Teaching and…
-
Kingmed Diagnostics and MegaRobo Technologies Join Forces to Pioneer Smart Medical Laboratories
•
Kingmed Diagnostics (SHA: 603882), a prominent independent medical laboratory headquartered in Guangdong, is poised to form a joint venture (JV) with MegaRobo Technologies, a Beijing-based firm renowned for its integration of robotics and artificial intelligence (AI) in life sciences. This strategic partnership aims to pioneer industry-standard medical laboratory automation solutions,…
-
China’s State Council Unveils 26 Initiatives to Enhance Grey-hair Economy
•
The State Council has unveiled the “Opinions on Developing the Grey-hair Economy to Boost Wellbeing of the Elderly,” outlining 26 initiatives aimed at enhancing the quality of life for the aging population through improved livelihood, product supply, industrial growth, and security measures. Key recommendations include the optimization of elderly health…
-
AbbVie Launches Continuous Infusion Therapy for Advanced Parkinson’s Disease in EU
•
AbbVie (NYSE: ABBV) has announced the launch of its dopamine replacement therapy, Produodopa (foslevodopa + foscarbidopa), in the European Union (EU) for the treatment of advanced Parkinson’s disease (PD). The therapy is indicated for patients experiencing severe motor fluctuations, hyperkinesia, or dyskinesia, and when other treatments fail to adequately control…
-
Shanghai Henlius Partners with China Resource Medicine to Enhance Product Accessibility
•
Shanghai Henlius Biotech Inc. (HKG: 2696) has announced a strategic partnership with China Resource Medicine Commercial Holdings Ltd. aimed at enhancing product accessibility across the market. Under the terms of the agreement, the two companies will collaborate on product marketing promotion, channel expansion, and supply chain management, although financial details…
-
AstraZeneca Launches Evinova to Enhance Global Clinical Development with Digital Health Solutions
•
UK-based AstraZeneca (AZ; NASDAQ: AZN) has launched Evinova, a digital health solutions provider, with the aim of supporting global clinical development. Evinova offers AI-enabled technologies and services to clinical trial (CT) sponsors, clinical research organizations (CROs), CT site care teams, and patients. The new business unit will initially focus on…
-
CIRC Unveils FuZhi 1.0 Smart Nuclear Medicine System at Chinese Medical Association Meeting
•
China Isotope & Radiation Corporation (CIRC; HKG: 1763) has announced the launch of its innovative FuZhi 1.0 smart nuclear medicine system at the 2023 annual meeting of the Nuclear Medicine Branch of the Chinese Medical Association. This comprehensive system, which includes modules for smart patient care, smart nuclear drug management,…
-
CSPC Pharmaceutical Group Partners with China Unicom for Digital Transformation
•
China-based CSPC Pharmaceutical Group Ltd (HKG: 1093) has announced a strategic partnership with Chinese mobile network giant China Unicom to empower the company’s digital transformation efforts. The collaboration will span across various fields, including novel drug research and clinical trials, smart manufacturing and production operations, smart marketing and logistics, management,…
-
Medtronic Launches AiBLE Orthopedic Ecosystem and Partners with Allinmd Orthopedics in China
•
US-based Medtronic Inc., (NYSE: MDT) has launched AiBLE, an innovative ecological ecosystem concept for orthopedics, in the Chinese market. This collaborative platform aims to connect industry, academia, research, and medicine, leveraging existing orthopedic integration platforms, industry chain capabilities, digitalization, and artificial intelligence technologies. With an open and collaborative approach, Medtronic…
-
Beijing’s E-Health Now Secures Tens of Millions in Series B Financing
•
E-Health Now, a comprehensive health management platform headquartered in Beijing, has reportedly raised tens of millions of renminbi in a Series B financing round. The round was led by Orient State-Owned Capital, with additional investments from Ventech China, GSR Ventures, LangRun Investment, and Tongji Fund. E-Health Now’s AI-Powered Digital Healthcare…
-
Kangrui Health Partners with West China Second University Hospital for Pediatric Care Innovation
•
Kangrui Health, a leading data and intelligence application company based in Beijing, has entered into a significant 10-year partnership with West China Second University Hospital. The collaboration focuses on the “Children’s Medical Counseling Game – Wonderful Hospital Series” technology translation project, which is set to revolutionize pediatric care approaches. West…
-
Siyi Intelligence Raises Series A Funding for Neural Rehabilitation Solutions
•
Siyi Intelligence, a developer of soft rehabilitation robots based in Shanghai, has reportedly raised close to RMB 100 million (USD 14.46 million) in a Series A financing round. The round was led by Chengdu Tianfu International Bio-town’s fund, with additional contributions from Tao Capital. The proceeds will be directed towards…
-
Abbott Partners with Sinopharm for Expanded Medical Solutions in China
•
US-based Abbott (NYSE: ABT) has entered into a strategic partnership with Sinopharm’s China National Medical Device Co., Ltd. The collaboration aims to leverage the respective strengths of both companies in technology, service network, and other areas to enhance the distribution of advanced medical technologies and solutions in China. Partnership Scope…
-
ThinmedTech Partners with West China Hospital for CKD Digital Therapy
•
ThinmedTech, a chronic disease clinical management solution provider based in Chongqing, has struck a partnership with West China Hospital. The collaboration aims to work together on medical research and product transformation in the area of “chronic kidney disease (CKD) sodium restriction digital therapy.” This partnership marks a significant step in…
-
Dessight Biomedical Secures Pre-Series A Funding for Ophthalmic Innovations
•
Hangzhou Dessight Biomedical has reportedly raised “tens of millions” of renminbi in a Pre-Series A financing round. This significant capital injection was led by Linear Venture, with GL Ventures also participating. The funds will be directed towards market filing for an ophthalmic surgery robot, the development of microsurgery robots, and…
-
Med Vision Secures Series A+ Funding to Expand Digital Therapy Portfolio
•
Med Vision, a Hangzhou-based digital therapy specialist, has reportedly raised “tens of millions” of renminbi in a Series A+ financing round. The funding was led by Hangzhou Lingxin Enterprise Management Partnership, with a contribution from existing investor Med-Fine Capital. The proceeds will be used to accelerate the commercialization of multiple…
-
Zhongchao Partners with Natco Pharma to Distribute Drugs in China
•
Zhongchao Inc. (NASDAQ: ZCMD), a Shanghai-based online health education provider, has announced multiple agreements with India-headquartered Natco Pharma Limited to become its distribution agent for certain drugs in mainland China. The collaboration aims to address domestic demand for influenza drugs, cancer therapies, and rare disease treatments. The two companies will…
-
Roche and Zhongshan Hospital Collaborate on Clinical Studies and Innovation Center
•
Swiss giant Roche’s (SWX: ROG) China unit and Roche Diagnostics’ China unit entered into a cooperation memorandum of understanding (MoU) with Shanghai’s Class 3A Zhongshan Hospital, a major teaching hospital affiliated to China’s National Health Commission. The three entities will collaborate on clinical studies in cancer and other diseases, create…
